Relationship of Alcohol Intake with Inflammatory Markers and Plasminogen Activator Inhibitior-1 in Well-Functioning Older Adults: The Health, Aging, and Body Composition Study

Circulation

Volumn 109, Issue 5, 2004, Pages 607-612

  Volpato, Stefano ^a,b   Pahor, Marco ^c   Ferrucci, Luigi ^d   Simonsick, Eleanor M ^b   Guralnik, Jack M ^b   Kritchevsky, Stephen B ^c   Fellin, Renato ^a   Harris, Tamara B ^b  

^a UNIVERSITY OF FERRARA   (Italy)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^d Geriatric Department   (Italy)

Author keywords

Aging; Alcohol; Epidemiology; Inflammation; Interleukins

Indexed keywords

ANTIINFLAMMATORY AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; PLASMINOGEN ACTIVATOR INHIBITOR 1; STATINE; TUMOR NECROSIS FACTOR ALPHA;

AFRICAN AMERICAN; AGE; AGED; AGING; ALCOHOL CONSUMPTION; ANAMNESIS; ARTICLE; BODY FAT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DRINKING BEHAVIOR; EPIDEMIOLOGICAL DATA; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RACE; SMOKING HABIT; UNITED STATES;

AGED; ALCOHOL DRINKING; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 1042263379     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000109503.13955.00     Document Type: Article

References (25)

1. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135-1143.
2. Volpato S, Guralnik JM, Ferrucci L, et al. Cardiovascular disease, interleukin-6 and the risk of mortality in older women: the Women's Health and Aging Study. Circulation. 2001;103:947-953.
3. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340:448-454.
4. Sierksma A, van der Gaag MS, Kluft C, et al. Effect of moderate alcohol consumption on fibrinogen levels in healthy volunteers is discordant with effects on C-reactive protein. Ann N Y Acad Sci. 2001;936:630-633.
5. Imhof A, Froehlich M, Brenner H, et al. Effect of alcohol consumption on systemic markers of inflammation. Lancet. 2001;357:763-767.
6. Albert MA, Glynn RJ, Ridker PM. Alcohol consumption and plasma concentration of C-reactive protein. Circulation. 2003;107:443-447.
7. Papanicolaou DA, Wilder RL, Manolagas SC, et al. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med. 1998;128:127-137.
8. McCarty MF. Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: down regulation with essential fatty acids, ethanol and pentoxifylline. Med Hypotheses. 1999;52:465-477.
9. Salgado A, Boveda JL, Monasterio J, et al. Inflammatory mediators and their influence on haemostasis. Haemostasis 1994;24:132-138.
10. Report of the Dietary Guidelines Advisory Committee: dietary guidelines for Americans, 1995. Nutr Rev. 1995;53:376-379.
11. DeClerck P, Alessi M, Verstreken M, et al. Measurement of plasminogen activator inhibitor 1 (PAI-1) in biological fluids with a murine monoclonal antibody based enzyme-linked immunosorbent assay. Blood. 1988;71:220-225.
12. Ainsworth BE, Haskell WL, Leon AS, et al. Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc. 1993;25:71-80.
13. Lee I-M, Rexrode KM, Cook NR, et al. Physical activity and coronary heart disease in women: is no pain, no gain passé? JAMA. 2001;285:1447-1455.
14. Pahor M, Chrischilles EA, Guralnik JM, et al. Drug data coding and analysis in epidemiologic studies. Eur J Epidemiol. 1994;10:405-411.
15. Goldberg RJ, Burchfiel CM, Reed DM, et al. A prospective study of the health effects of alcohol consumption in middle-aged and elderly men: the Honolulu Heart Program. Circulation. 1994;89:651-659.
16. Ruitenberg A, van Swieten JC, Witteman JC, et al. Alcohol consumption and risk of dementia: the Rotterdam Study. Lancet. 2002;26;359:281-286.
17. Sierksma A, van der Gaag MS, Kluft C, et al. Moderate alcohol consumption reduces plasma C-reactive protein and fibrinogen levels; a randomized, diet-controlled intervention study. Eur J Clin Nutr. 2002;56:1130-1136.
18. Stewart SH, Mainous AG III, Gilbert G. Relation between alcohol consumption and C-reactive protein levels in the adult US population. J Am Board Fam Pract. 2002;15:437-442.
19. Yudkin JS, Kumari M, Humphries SE, et al. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis. 2000;148:209-214.
20. Tilg H, Diehl AM. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med. 2000;343:1467-1476.
21. Deaciuc IV, Alappat JM, McDonougg KH, et al. Effect of chronic alcohol consumption by rates on tumor necrosis factor-α and interleukin-6 clearance in vivo and by isolated, perfused liver. Biochem Pharmacol. 1996;52:891-899.
22. Samad F, Uysal KT, Wiesbrock SM, et al. Tumor necrosis factor alpha is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1. Proc Natl Acad Sci U S A. 1999;96:6902-6907.
23. Kohler HP, Grant PJ. Plasminogen-activator inhibitor type I and coronary artery disease. N Engl J Med. 2000;342:1792-1801.
24. McConnell MV, Vavouranakis I, Wu LL, et al. Effects of a single, daily alcoholic beverage on lipid and hemostatic markers of cardiovascular risk. Am J Cardiol. 1997;80:1226-1228.
25. Di Castelnuovo A, Rotondo S, Iacoviello L, et al. Meta-analysis of wine and beer consumption in relation to vascular risk. Circulation. 2002;105:2836-2844.